Correction: Neurological manifestations of SARS-CoV-2 infection: protocol for a sub-analysis of the COVID-19 critical care consortium observational study - Scorecard - MDSpire

Correction: Neurological manifestations of SARS-CoV-2 infection: protocol for a sub-analysis of the COVID-19 critical care consortium observational study

  • By

  • Denise Battaglini

  • Lavienraj Premraj

  • Matthew Griffee

  • Samuel Huth

  • Jonathon Fanning

  • Glenn Whitman

  • Diego Bastos Porto

  • Rakesh Arora

  • Lucian Durham

  • Eric Gnall

  • Marcelo Amato

  • Virginie Williams

  • Alexandre Noel

  • Sabrina Araujo De Franca

  • Gordan Samoukovic

  • Bambang Pujo

  • David Kent

  • Eva Marwali

  • Abdulrahman Al-Fares

  • Stephanie-Susanne Stecher

  • Mauro Panigada

  • Marco Giani

  • Giuseppe Foti

  • Paolo Pelosi

  • Antonio Pesenti

  • Nicole Marie White

  • Gianluig Li Bassi

  • Jacky Suen

  • John F. Fraser

  • Chiara Robba

  • Sung-Min Cho

  • May 1, 2026

  • 0 min

Share

Clinical Scorecard: Correction: Neurological Effects Associated with SARS-CoV-2 Infection: A Sub-Analysis Protocol from the COVID-19 Critical Care Consortium Observational Study

At a Glance

CategoryDetail
ConditionNeurological manifestations of SARS-CoV-2 infection
Key MechanismsNeurological effects related to COVID-19 infection
Target PopulationPatients with COVID-19 in critical care settings
Care SettingCritical care units

Key Highlights

  • Correction of classification in the modified Rankin Scale (mRS) domains
  • Focus on neurological manifestations of SARS-CoV-2
  • Sub-analysis from the COVID-19 Critical Care Consortium study
  • Importance of accurate data representation in clinical research
  • Updated figure provided for clarity

Guideline-Based Recommendations

Diagnosis

  • Utilize the modified Rankin Scale for assessing neurological outcomes

Management

  • Monitor neurological symptoms in COVID-19 patients

Monitoring & Follow-up

  • Regular assessment of neurological status in critical care

Risks

  • Potential for misclassification of neurological impairment

Patient & Prescribing Data

Patients with COVID-19 experiencing neurological symptoms

Focus on comprehensive neurological assessment and management

Clinical Best Practices

  • Ensure accurate classification of neurological scales
  • Incorporate neurological assessments in routine COVID-19 care
  • Update clinical protocols based on corrected data

References

Original Source(s)

Correction: Neurological manifestations of SARS-CoV-2 infection: protocol for a sub-analysis of the COVID-19 critical care consortium observational study

  • by Denise Battaglini, Lavienraj Premraj, Matthew Griffee, Samuel Huth, Jonathon Fanning, Glenn Whitman, Diego Bastos Porto, Rakesh Arora, Lucian Durham, Eric Gnall, Marcelo Amato, Virginie Williams, Alexandre Noel, Sabrina Araujo De Franca, Gordan Samoukovic, Bambang Pujo, David Kent, Eva Marwali, Abdulrahman Al-Fares, Stephanie-Susanne Stecher, Mauro Panigada, Marco Giani, Giuseppe Foti, Paolo Pelosi, Antonio Pesenti, Nicole Marie White, Gianluig Li Bassi, Jacky Suen, John F. Fraser, Chiara Robba, Sung-Min Cho

  • May 1, 2026

Related Content

COVID-19 webinar: COVID-19 and the rapid transition to a virtual practice

John D. Halamka, M.D., M.S., president of the Mayo Clinic Platform, and other Mayo Clinic experts discuss advanced telemedicine and the role this alternative care setting will play amid an evolving health care landscape. (Credit is available.)

  • September 3, 2020

  • 1 min
Oncologic impact of delaying radical prostatectomy in men with intermediate- and high-risk prostate cancer: a systematic review

COVID Vaccines: Ask The Experts with Dr. Anthony Fauci

Dr. Anthony Fauci and a panel of public health experts gathered live to discuss the COVID-19 pandemic in Florida and answer questions about the vaccines.

  • February 15, 2021

  • 1 min